chr2-61071634-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001129993.3(SANBR):c.179G>T(p.Ser60Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000757 in 1,572,974 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001129993.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SANBR | NM_001129993.3 | c.179G>T | p.Ser60Ile | missense_variant | 4/22 | ENST00000402291.6 | NP_001123465.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SANBR | ENST00000402291.6 | c.179G>T | p.Ser60Ile | missense_variant | 4/22 | 1 | NM_001129993.3 | ENSP00000385579.1 |
Frequencies
GnomAD3 genomes AF: 0.000382 AC: 58AN: 151950Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000136 AC: 29AN: 213350Hom.: 0 AF XY: 0.000103 AC XY: 12AN XY: 116024
GnomAD4 exome AF: 0.0000429 AC: 61AN: 1420918Hom.: 0 Cov.: 29 AF XY: 0.0000382 AC XY: 27AN XY: 706150
GnomAD4 genome AF: 0.000381 AC: 58AN: 152056Hom.: 1 Cov.: 32 AF XY: 0.000350 AC XY: 26AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 08, 2023 | The c.179G>T (p.S60I) alteration is located in exon 4 (coding exon 2) of the KIAA1841 gene. This alteration results from a G to T substitution at nucleotide position 179, causing the serine (S) at amino acid position 60 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at